Skip to main content

The first four items on this menu are active

but a login is needed to access the remaining content on this menu. Please Register for your free login.

Imunexus

Converting Antibodies into Bispecifics. Imunexus' technology facilitates rapid, cost-effective, lower risk, generation of effective therapeutics by converting existing monoclonal antibodies into multispecifics with additional therapeutic utility.
QR code VCard
https://digitalaustralia.net/media/com_jbusinessdirectory/pictures/item/www_imunexus_com.png
Imunexus
Categories:
Medicines & Pharmaceuticals,  Melbourne
Claim listing
SHARE
Click to enlarge
  • Details

Screen-Shot-2023-06-21-at-104153-am

Type
Business Organisation